Mechanisms of T cell peptide epitope-dependent late asthmatic reactions

International Archives of Allergy and Immunology

Volumn 124, Issue 1-3, 2001, Pages 272-275

  Larché, Mark ^a   Haselden, Brigitte M ^a   Oldfield, William L G ^a   Shirley, Karen ^a   North, Janet ^a   Meng, Qiu ^a   Robinson, Douglas S ^a   Ying, Sun ^a   Kay, A Barry ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Asthma; Peptide; T cell

Indexed keywords

ALLERGEN; CELL PROTEIN; EPITOPE; HLA DR ANTIGEN;

ALLERGIC ASTHMA; AMINO ACID SEQUENCE; BRONCHOSPASM; CONFERENCE PAPER; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; LUNG FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ASTHMA; CATS; CELL LINE; EPITOPES; FORCED EXPIRATORY VOLUME; GLYCOPROTEINS; HLA-DR ANTIGENS; HUMANS; HYPERSENSITIVITY; LYMPHOCYTE ACTIVATION; PEPTIDES; T-LYMPHOCYTES;

EID: 0035045515     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053730     Document Type: Conference Paper

References (27)

1. Concepts of allergy and hypersensitivity
2. Messenger RNA expression of the cytokine gene cluster, IL-3, IL-4, IL-5 and GM-CSF in allergen-induced late-phase cutaneous reactions in atopic subjects
3. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
4. Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in atopic asthmatics
5. T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status
6. Randomised, dose-ranging, placebo controlled study of a chimeric antibody to CD4 (keliximab) in chronic severe asthma
7. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma
8. Molecular components of T-cell recognition
9. Costimulation through CD86 is involved in airway presenting cell and T cell responses to allergen in atopic asthmatics
10. T cell clonal anergy
11. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I
12. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice
13. The specificity and regulation of T-cell responsiveness to allergens
14. Treatment of cat allergy with T-cell reactive peptides
15. Fel d 1 peptides: Effect on skin tests and cytokine synthesis in cat-allergic human subjects
16. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom
17. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions
18. Identification of a highly promiscuous and an HLA allele-specific T-cell epitope in the birch major allergen Bet v 1: HLA restriction, epitope mapping and TCR sequence comparisons
19. HLA-DR restricted peptide candidates for bee venom immunotherapy
20. Eosinophils: Biology and role in disease
21. The role of neurotrophins in allergic bronchial asthma
22. T lymphocytes adhere to airway smooth muscle cells via inte-grins and CD44 and induce smooth muscle cell DNA synthesis
23. Cytokines in symptomatic asthma airways
24. Mechanisms underlying TNFα effects on agonist-mediated calcium homeostasis in human airway smooth muscle cells
25. Cellular and molecular mechanisms regulating airway smooth muscle cell physiology and pharmacology
26. Interleukin-13: Central mediator of allergic asthma
27. Requirement for IL-13 independently of IL-4 in experimental asthma